{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T05:54:29Z","timestamp":1721195669980},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,3,1]],"date-time":"2001-03-01T00:00:00Z","timestamp":983404800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2001,3]]},"DOI":"10.1053\/ejso.2000.1074","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T13:56:27Z","timestamp":1032443787000},"page":"203-208","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of putative molecular biomarkers in abdominal and retroperitoneal leiomyosarcomas"],"prefix":"10.1053","volume":"27","author":[{"given":"B.","family":"Shpitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Tiomkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Bomstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gralkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Buklan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Bernheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/ejso.2000.1074_RF1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-0320(19970901)29:1<1::AID-CYTO1>3.0.CO;2-J","article-title":"Common patterns of genetic evolution in human solid tumors","volume":"29","author":"Shackney","year":"1997","journal-title":"Cytometry"},{"key":"10.1053\/ejso.2000.1074_RF2","first-page":"515","article-title":"Immunohistochemical and molecular genetic approaches to soft tissue tumor diagnosis: a primer","volume":"24","author":"Hibshoosh","year":"1997","journal-title":"Semin Oncol"},{"key":"10.1053\/ejso.2000.1074_RF3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00048060","article-title":"The involvement of oncogenes and tumor suppressor genes in the control of apoptosis","volume":"11","author":"Oren","year":"1992","journal-title":"Cancer Metast Rev"},{"key":"10.1053\/ejso.2000.1074_RF4","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1182\/blood.V80.4.879.879","article-title":"bcl-2 initiates a new category of oncogenes: regulators of cell death","volume":"80","author":"Korsmeyer","year":"1992","journal-title":"Blood"},{"key":"10.1053\/ejso.2000.1074_RF5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2796.1995.tb00881.x","article-title":"Apoptosis: molecular mechanisms and implications for human disease","volume":"237","author":"Orrenius","year":"1995","journal-title":"J Intern Med"},{"key":"10.1053\/ejso.2000.1074_RF6","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1365-2559.1996.333377.x","article-title":"MIB-1 expression and iododeoxyuridine labelling in soft tissue sarcomas: an immunohistochemical study including correlations with p53, bcl-2 and histological characteristics","volume":"28","author":"Jensen","year":"1996","journal-title":"Histopathology"},{"key":"10.1053\/ejso.2000.1074_RF7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev.med.47.1.285","article-title":"Clinical implications of the gene","volume":"47","author":"Sidransky","year":"1996","journal-title":"Ann Rev Med"},{"key":"10.1053\/ejso.2000.1074_RF8","doi-asserted-by":"crossref","first-page":"7491","DOI":"10.1073\/pnas.89.16.7491","article-title":"Wild-type p53 is a cell cycle checkpoint determinant following irradiation","volume":"89","author":"Kuerbitz","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/ejso.2000.1074_RF9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.1905840","article-title":"P53 mutations in human cancers","volume":"253","author":"Hollstein","year":"1991","journal-title":"Science"},{"key":"10.1053\/ejso.2000.1074_RF10","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1200\/JCO.1997.15.10.3249","article-title":"Evaluation of newer prognostic markers in soft tissue sarcomas","volume":"10","author":"Levine","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/ejso.2000.1074_RF11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-2559.1998.00425.x","article-title":"Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas","volume":"32","author":"Jensen","year":"1998","journal-title":"Histopathology"},{"key":"10.1053\/ejso.2000.1074_RF12","first-page":"1997","article-title":"Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma","volume":"150","author":"Rudolph","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1053\/ejso.2000.1074_RF13","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67","volume":"133","author":"Gerdes","year":"1984","journal-title":"J Immunol"},{"key":"10.1053\/ejso.2000.1074_RF14","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<490::AID-CNCR18>3.0.CO;2-R","article-title":"Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high grade extremity soft tissue sarcoma","volume":"83","author":"Helsin","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/ejso.2000.1074_RF15","first-page":"199","article-title":"Ki-67 and other proliferation markers useful for immunohistological diagnosis and prognostic evaluations in human malignancies","volume":"1","author":"Gerdes","year":"1990","journal-title":"Semin Cancer Biol"},{"key":"10.1053\/ejso.2000.1074_RF16","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1002\/1097-0142(19940515)73:10<2499::AID-CNCR2820731008>3.0.CO;2-G","article-title":"Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor","volume":"73","author":"Kawai","year":"1994","journal-title":"Cancer"},{"key":"10.1053\/ejso.2000.1074_RF17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/jnci\/86.7.549","article-title":"Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft-tissue sarcomas","volume":"86","author":"Drobnjak","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/ejso.2000.1074_RF18","first-page":"91","article-title":"P53, proliferating cell nuclear antigen, and Ki-67 expression in extrauterine leiomyosarcomas","volume":"10","author":"O\u00bbReilly","year":"1997","journal-title":"Mod Pathol"},{"key":"10.1053\/ejso.2000.1074_RF19","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000227695","article-title":"Immunohistochemical detection of bcl-2 and p53 proteins and apoptosis in soft tissue sarcoma: their correlations with prognosis","volume":"54","author":"Nakanishi","year":"1997","journal-title":"Oncology"},{"key":"10.1053\/ejso.2000.1074_RF20","first-page":"468","article-title":"p53 abnormalities in different subtypes of human sarcomas","volume":"53","author":"Andreassen","year":"1993","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2000.1074_RF21","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2559.1993.tb00068.x","article-title":"p53 protein expression in non-neoplastic lesions and benign and malignant neoplasms of soft tissue","volume":"22","author":"Dei Tos","year":"1993","journal-title":"Histopathology"},{"key":"10.1053\/ejso.2000.1074_RF22","first-page":"2231","article-title":"p53 mutation and MDM2 amplification in human soft tissue sarcomas","volume":"53","author":"Leach","year":"1993","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2000.1074_RF23","first-page":"395","article-title":"p53 gene mutations and p53 protein expression in human soft tissue sarcomas","volume":"121","author":"Yoo","year":"1997","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/ejso.2000.1074_RF24","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00000478-199807000-00008","article-title":"Expression of bcl-2 oncoprotein in benign and malignant spindle cell tumors of soft tissue, skin, serosal surfaces, and gastrointestinal tract","volume":"22","author":"Suster","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/ejso.2000.1074_RF25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/gyno.1997.4889","article-title":"Leiomyosarcoma of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2. Analysis of 49 cases","volume":"68","author":"Blom","year":"1998","journal-title":"Gynecol Oncol"},{"key":"10.1053\/ejso.2000.1074_RF26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2559.1996.288334.x","article-title":"bcl-2 is preferentially expressed in tumors of muscle origin but is not related to p53 expression","volume":"28","author":"Soini","year":"1996","journal-title":"Histopathology"},{"key":"10.1053\/ejso.2000.1074_RF27","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.1073\/pnas.91.13.5878","article-title":"c-myc and bcl-2 modulate p53 junction by altering p53 subcellular trafficking during the cell cycle","volume":"91","author":"Ryan","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1053\/ejso.2000.1074_RF28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2559.1993.tb00067.x","article-title":"Immunohistochemical detection of p53 and bcl-2 protein in non-Hodgkin's lymphoma","volume":"22","author":"Pezzella","year":"1993","journal-title":"Histopathology"},{"key":"10.1053\/ejso.2000.1074_RF29","first-page":"237","volume":"55","author":"Sinicrope","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/ejso.2000.1074_RF30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jnci\/86.7.499","article-title":"The bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients","volume":"86","author":"Silvestrini","year":"1994","journal-title":"J Natl Cancer Inst"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798300910746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798300910746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T04:56:34Z","timestamp":1682139394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798300910746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,3]]}},"alternative-id":["S0748798300910746"],"URL":"https:\/\/doi.org\/10.1053\/ejso.2000.1074","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2001,3]]}}}